EGEIRO Pharma
ALVET
Company Profile
Business description
EGEIRO Pharma is a biopharmaceutical company. The company is focused on the clinical development of drugs for Idiopathic Pulmonary Fibrosis, a chronic, devastating, and fatal disease characterized by the deterioration of lung function.
Contact
Avenue Jean Mermoz 32/1
Gosselies6041
BELSector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
5
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,980.40 | 18.70 | 0.23% |
| CAC 40 | 7,329.97 | 5.43 | -0.07% |
| DAX 40 | 21,311.02 | 57.32 | 0.27% |
| Dow JONES (US) | 39,669.39 | 699.57 | -1.73% |
| FTSE 100 | 8,275.60 | 26.48 | 0.32% |
| HKSE | 21,288.02 | 231.04 | 1.10% |
| NASDAQ | 16,307.16 | 516.01 | -3.07% |
| Nikkei 225 | 34,187.53 | 267.13 | 0.79% |
| NZX 50 Index | 12,116.60 | 48.68 | 0.40% |
| S&P 500 | 5,275.70 | 120.93 | -2.24% |
| S&P/ASX 200 | 7,777.50 | 18.60 | 0.24% |
| SSE Composite Index | 3,275.16 | 0.84 | -0.03% |